Pierluigi Navarra - Publications

Affiliations: 
catholic University Medical School, Washington, DC, United States 
Area:
Neuroendocrinology

144 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Dello Russo C, Di Franco V, Tabolacci E, Cappoli N, Navarra P, Sollazzi L, Rapido F, Aceto P. Remifentanil-induced hyperalgesia in healthy volunteers: a systematic review and meta-analysis of randomized controlled trials. Pain. PMID 38047761 DOI: 10.1097/j.pain.0000000000003119  0.561
2023 Tringali G, Pizzoferrato M, Lisi L, Marinelli S, Buccarello L, Falsini B, Cattaneo A, Navarra P. A Vicious NGF-p75 Positive Feedback Loop Exacerbates the Toxic Effects of Oxidative Damage in the Human Retinal Epithelial Cell Line ARPE-19. International Journal of Molecular Sciences. 24. PMID 38003427 DOI: 10.3390/ijms242216237  0.529
2023 Lisi L, Pizzoferrato M, Ciotti GMP, Martire M, Navarra P. mTOR Inhibition Is Effective against Growth, Survival and Migration, but Not against Microglia Activation in Preclinical Glioma Models. International Journal of Molecular Sciences. 24. PMID 37372982 DOI: 10.3390/ijms24129834  0.547
2023 Dello Russo C, Cappoli N, Tabolacci E, Sollazzi L, Navarra P, Aceto P. Remifentanil does not affect human microglial immune activation in response to pro-inflammatory cytokines. Excli Journal. 22: 295-309. PMID 37220493 DOI: 10.17179/excli2022-5667  0.643
2023 Dello Russo C, Navarra P. What is the weight of expectation bias in oncology trials? British Journal of Clinical Pharmacology. PMID 36772876 DOI: 10.1111/bcp.15680  0.53
2023 De Pascale G, Pintaudi G, Lisi L, De Maio F, Cutuli SL, Tanzarella ES, Carelli S, Lombardi G, Cesarano M, Gennenzi V, Ciotti GMP, Grieco DL, Posteraro B, Sanguinetti M, Navarra P, et al. Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible VAP: Clinical, Pharmacokinetic and Microbiome Features. Antibiotics (Basel, Switzerland). 12. PMID 36671325 DOI: 10.3390/antibiotics12010125  0.482
2022 Lisi L, Marinelli S, Ciotti GMP, Pizzoferrato M, Palmerio F, Chiavari M, Cattaneo A, Navarra P. The effects of painless nerve growth factor on human microglia polarization. Frontiers in Cellular Neuroscience. 16: 969058. PMID 36339818 DOI: 10.3389/fncel.2022.969058  0.511
2022 Dello Russo C, Navarra P. Local Investigators Significantly Overestimate Overall Response Rates Compared to Blinded Independent Central Reviews in Uncontrolled Oncology Trials: A Comprehensive Review of the Literature. Frontiers in Pharmacology. 13: 858354. PMID 35652050 DOI: 10.3389/fphar.2022.858354  0.572
2022 Lisi L, Ciotti GMP, Chiavari M, Martire M, Navarra P. The effects of CHF6467, a new mutated form of NGF, on cell models of human glioblastoma. A comparison with wild-type NGF. Growth Factors (Chur, Switzerland). 1-9. PMID 35442129 DOI: 10.1080/08977194.2022.2060095  0.502
2022 Graziani G, Lisi L, Tentori L, Navarra P. Monoclonal Antibodies to CTLA-4 with Focus on Ipilimumab. Experientia Supplementum (2012). 113: 295-350. PMID 35165868 DOI: 10.1007/978-3-030-91311-3_10  0.522
2022 Lisi L, Lacal PM, Martire M, Navarra P, Graziani G. Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironment. Pharmacological Research. 175: 105997. PMID 34826600 DOI: 10.1016/j.phrs.2021.105997  0.511
2020 Chiavari M, Ciotti GMP, Canonico F, Altieri F, Lacal PM, Graziani G, Navarra P, Lisi L. PDIA3 Expression in Glioblastoma Modulates Macrophage/Microglia Pro-Tumor Activation. International Journal of Molecular Sciences. 21. PMID 33153019 DOI: 10.3390/ijms21218214  0.563
2020 Cutuli SL, De Pascale G, Lisi L, Carelli S, Navarra P, Antonelli M. Tigecycline pharmacokinetics in critically ill patients on renal replacement therapy: possible warnings and potential perspectives for the research agenda. Annals of Intensive Care. 10: 141. PMID 33052543 DOI: 10.1186/s13613-020-00759-4  0.444
2020 De Pascale G, Lisi L, Ciotti GMP, Vallecoccia MS, Cutuli SL, Cascarano L, Gelormini C, Bello G, Montini L, Carelli S, Di Gravio V, Tumbarello M, Sanguinetti M, Navarra P, Antonelli M. Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections. Annals of Intensive Care. 10: 94. PMID 32661791 DOI: 10.1186/S13613-020-00715-2  0.51
2020 Dello Russo C, Cappoli N, Navarra P. A comparison between the assessments of progression-free survival by local investigators versus blinded independent central reviews in phase III oncology trials. European Journal of Clinical Pharmacology. PMID 32447437 DOI: 10.1007/S00228-020-02895-Z  0.591
2020 Lisi L, Pia Ciotti GM, Chiavari M, Ruffini F, Lacal PM, Graziani G, Navarra P. Vascular endothelial growth factor receptor 1 in glioblastoma‑associated microglia/macrophages. Oncology Reports. PMID 32236632 DOI: 10.3892/Or.2020.7553  0.567
2020 Lisi L, Chiavari M, Ciotti GMP, Lacal PM, Navarra P, Graziani G. DNA inhibitors for the treatment of brain tumors. Expert Opinion On Drug Metabolism & Toxicology. PMID 32067518 DOI: 10.1080/17425255.2020.1729352  0.565
2019 Cappoli N, Mezzogori D, Tabolacci E, Coletta I, Navarra P, Pani G, Dello Russo C. The mTOR kinase inhibitor rapamycin enhances the expression and release of pro-inflammatory cytokine interleukin 6 modulating the activation of human microglial cells. Excli Journal. 18: 779-798. PMID 31645839 DOI: 10.17179/Excli2019-1715  0.692
2019 Pozzoli G, Petrucci G, Navarra P, Marei HE, Cenciarelli C. Aspirin inhibits proliferation and promotes differentiation of neuroblastoma cells via p21 protein up-regulation and Rb1 pathway modulation. Journal of Cellular and Molecular Medicine. PMID 31429199 DOI: 10.1111/Jcmm.14610  0.349
2019 Lisi L, Pia Ciotti GM, Chiavari M, Pizzoferrato M, Mangiola A, Kalinin S, Feinstein DL, Navarra P. Phospho-mTOR expression in human glioblastoma microglia-macrophage cells. Neurochemistry International. 104485. PMID 31195027 DOI: 10.1016/J.Neuint.2019.104485  0.691
2019 Chiavari M, Ciotti GMP, Navarra P, Lisi L. Pro-Inflammatory Activation of A New Immortalized Human Microglia Cell Line. Brain Sciences. 9. PMID 31096716 DOI: 10.3390/Brainsci9050111  0.585
2019 Dello Russo C, Gagliardi D, Ramlogan R, Navarra P. Optimizing Patient Selection to Maximize Drug Efficacy: the Expanding Role of Pharmacogenomics in the Clinical Development of Pembrolizumab for the Treatment of Non-Small Cell Lung Cancer. Clinical Therapeutics. PMID 31030994 DOI: 10.1016/J.Clinthera.2019.04.002  0.621
2019 Tringali G, Navarra P. Anti-CGRP and anti-CGRP receptor monoclonal antibodies as antimigraine agents. Potential differences in safety profile postulated on a pathophysiological basis. Peptides. 116: 16-21. PMID 31018157 DOI: 10.1016/J.Peptides.2019.04.012  0.311
2019 Pozzoli G, Marei HE, Althani A, Boninsegna A, Casalbore P, Marlier LNJL, Lanzilli G, Zonfrillo M, Petrucci G, Rocca B, Navarra P, Sgambato A, Cenciarelli C. Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation. Journal of Cellular Physiology. PMID 30701538 DOI: 10.1002/Jcp.28194  0.354
2018 Dello Russo C, Cappoli N, Coletta I, Mezzogori D, Paciello F, Pozzoli G, Navarra P, Battaglia A. The human microglial HMC3 cell line: where do we stand? A systematic literature review. Journal of Neuroinflammation. 15: 259. PMID 30200996 DOI: 10.1186/S12974-018-1288-0  0.631
2017 Rossetti B, Gagliardini R, Meini G, Sterrantino G, Colangeli V, Re MC, Latini A, Colafigli M, Vignale F, Rusconi S, Micheli V, Di Biagio A, Orofino G, Ghisetti V, Fantauzzi A, ... ... Navarra P, et al. Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trial. Plos One. 12: e0187393. PMID 29161288 DOI: 10.1371/Journal.Pone.0187393  0.516
2017 Atzori MG, Tentori L, Ruffini F, Ceci C, Lisi L, Bonanno E, Scimeca M, Eskilsson E, Daubon T, Miletic H, Ricci Vitiani L, Pallini R, Navarra P, Bjerkvig R, D'Atri S, et al. The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells. Journal of Experimental & Clinical Cancer Research : Cr. 36: 106. PMID 28797294 DOI: 10.1186/S13046-017-0577-2  0.523
2017 Lisi L, Pizzoferrato M, Miscioscia FT, Topai A, Navarra P. Interactions between Integrase Inhibitors and human Arginase 1. Journal of Neurochemistry. PMID 28397245 DOI: 10.1111/Jnc.14039  0.589
2017 Laudati E, Currò D, Navarra P, Lisi L. Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm. Neurochemistry International. PMID 28279751 DOI: 10.1016/J.Neuint.2017.03.002  0.606
2017 Lisi L, Ciotti GM, Braun D, Kalinin S, Currò D, Dello Russo C, Coli A, Mangiola A, Anile C, Feinstein DL, Navarra P. Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma. Neuroscience Letters. 645: 106-112. PMID 28259657 DOI: 10.1016/J.Neulet.2017.02.076  0.75
2017 Lisi L, Graziani G, Navarra P. Macrophages/microglia in glioblastoma: a Zelig-like story of changing phenotypes Translational Cancer Research. 6. DOI: 10.21037/15144  0.556
2016 Dello Russo C, Lisi L, Tentori L, Navarra P, Graziani G, Combs CK. Exploiting Microglial Functions for the Treatment of Glioblastoma. Current Cancer Drug Targets. PMID 27528361 DOI: 10.2174/1568009616666160813191240  0.715
2016 Falasca F, Dello Russo C, Mora B, Pirazzoli A, Fantauzzi A, Navarra P, Pizzuti A, De Vito C, Antonelli G, Turriziani O. COMPARATIVE ANALYSIS OF REAL-TIME PCR METHODS TO TYPING HLA-B*57:01 IN HIV- 1 POSITIVE PATIENTS. Aids Research and Human Retroviruses. PMID 26750774 DOI: 10.1089/Aid.2015.0303  0.592
2016 Greco MC, Capuano A, Navarra P, Tringali G. Lacosamide inhibits calcitonin gene-related peptide production and release at trigeminal level in the rat European Journal of Pain (United Kingdom). 20: 959-966. DOI: 10.1002/Ejp.820  0.363
2015 Greco MC, Navarra P, Tringali G. The analgesic agent tapentadol inhibits calcitonin gene-related peptide release from isolated rat brainstem via a serotonergic mechanism. Life Sciences. PMID 26706288 DOI: 10.1016/J.Lfs.2015.12.032  0.321
2015 Lisi L, Laudati E, Miscioscia TF, Dello Russo C, Topai A, Navarra P. Antiretrovirals inhibit arginase in human microglia. Journal of Neurochemistry. PMID 26466119 DOI: 10.1111/Jnc.13393  0.743
2015 Pozzoli G, De Simone ML, Cantalupo E, Cenciarelli C, Lisi L, Boninsegna A, Dello Russo C, Sgambato A, Navarra P. The activation of type 1 corticotropin releasing factor receptor (CRF-R1) inhibits proliferation and promotes differentiation of neuroblastoma cells in vitro via p27(Kip1) protein up-regulation and c-Myc mRNA down-regulation. Molecular and Cellular Endocrinology. 412: 205-15. PMID 25960164 DOI: 10.1016/J.Mce.2015.05.004  0.734
2015 Lisi L, Aceto P, Navarra P, Dello Russo C. mTOR kinase: a possible pharmacological target in the management of chronic pain. Biomed Research International. 2015: 394257. PMID 25685786 DOI: 10.1155/2015/394257  0.692
2015 Scarsi C, Levesque A, Lisi L, Navarra P. The free fractions of circulating docosahexaenoic acid and eicosapentenoic acid as optimal end-point of measure in bioavailability studies on n-3 fatty acids. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 96: 11-6. PMID 25559240 DOI: 10.1016/J.Plefa.2014.12.006  0.519
2014 Imberti R, De Gregori S, Lisi L, Navarra P. Influence of the oral dissolution time on the absorption rate of locally administered solid formulations for oromucosal use: the flurbiprofen lozenges paradigm. Pharmacology. 94: 143-7. PMID 25277061 DOI: 10.1159/000367663  0.55
2014 Lisi L, Laudati E, Navarra P, Dello Russo C. The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype. Journal of Neuroinflammation. 11: 125. PMID 25051975 DOI: 10.1186/1742-2094-11-125  0.74
2014 Capuano A, Greco MC, Navarra P, Tringali G. Correlation between algogenic effects of calcitonin-gene-related peptide (CGRP) and activation of trigeminal vascular system, in an in vivo experimental model of nitroglycerin-induced sensitization. European Journal of Pharmacology. 740: 97-102. PMID 24998872 DOI: 10.1016/J.Ejphar.2014.06.046  0.332
2014 Lisi L, Stigliano E, Lauriola L, Navarra P, Dello Russo C. Proinflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/B polarized cells. Asn Neuro. 6: 171-83. PMID 24689533 DOI: 10.1042/An20130045  0.741
2014 Greco MC, Lisi L, Currò D, Navarra P, Tringali G. Tapentadol inhibits calcitonin gene-related peptide release from rat brainstem in vitro. Peptides. 56: 8-13. PMID 24662320 DOI: 10.1016/J.Peptides.2014.03.009  0.583
2014 Dello Russo C, Lisi L, Fabbiani M, Gagliardi D, Fanti I, Di Giambenedetto S, Cauda R, Navarra P. Detection of HLA-B*57:01 by real-time PCR: implementation into routine clinical practice and additional validation data. Pharmacogenomics. 15: 319-27. PMID 24533711 DOI: 10.2217/Pgs.13.242  0.686
2014 Lisi L, Tramutola A, Navarra P, Dello Russo C. Antiretroviral agents increase NO production in gp120/IFNγ-stimulated cultures of rat microglia via an arginase-dependent mechanism. Journal of Neuroimmunology. 266: 24-32. PMID 24268674 DOI: 10.1016/J.Jneuroim.2013.10.013  0.744
2013 Aceto P, Lai C, Perilli V, Dello Russo C, Federico B, Navarra P, Proietti R, Sollazzi L. Stress-related biomarkers of dream recall and implicit memory under anaesthesia. Anaesthesia. 68: 1141-7. PMID 23952901 DOI: 10.1111/Anae.12386  0.584
2013 Fortuna S, Fabbiani M, Digiambenedetto S, Ragazzoni E, Lisi L, Cauda R, Navarra P. Variability of raltegravir plasma levels in the clinical setting. Pharmacology. 92: 43-8. PMID 23887354 DOI: 10.1159/000351851  0.538
2013 Fortuna S, Ragazzoni E, Lisi L, Di Giambenedetto S, Fabbiani M, Navarra P. Validation of an UPLC-MS/MS method for quantitative analysis of raltegravir in human plasma samples. Therapeutic Drug Monitoring. 35: 258-63. PMID 23407478 DOI: 10.1097/Ftd.0B013E318280110D  0.515
2013 Lisi L, Camardese G, Treglia M, Tringali G, Carrozza C, Janiri L, Dello Russo C, Navarra P. Monocytes from depressed patients display an altered pattern of response to endotoxin challenge. Plos One. 8: e52585. PMID 23300980 DOI: 10.1371/Journal.Pone.0052585  0.72
2013 Lisi L, McGuire S, Sharp A, Chiosis G, Navarra P, Feinstein DL, Dello Russo C. The novel HSP90 inhibitor, PU-H71, suppresses glial cell activation but weakly affects clinical signs of EAE. Journal of Neuroimmunology. 255: 1-7. PMID 23123171 DOI: 10.1016/J.Jneuroim.2012.10.008  0.764
2013 Dello Russo C, Lisi L, Feinstein DL, Navarra P. mTOR kinase, a key player in the regulation of glial functions: relevance for the therapy of multiple sclerosis. Glia. 61: 301-11. PMID 23044764 DOI: 10.1002/Glia.22433  0.769
2012 Tringali G, Greco MC, Lisi L, Pozzoli G, Navarra P. Cortistatin modulates the expression and release of corticotrophin releasing hormone in rat brain. Comparison with somatostatin and octreotide. Peptides. 34: 353-9. PMID 22342595 DOI: 10.1016/J.Peptides.2012.02.004  0.598
2012 Lisi L, Navarra P, Cirocchi R, Sharp A, Stigliano E, Feinstein DL, Dello Russo C. Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 243: 43-51. PMID 22264993 DOI: 10.1016/J.Jneuroim.2011.12.018  0.752
2012 Tringali G, Greco MC, Capuano A, Guerriero G, Currò D, Navarra P. Flupirtine inhibits calcitonin-gene related peptide release from rat brainstem in vitro. Neuroscience Letters. 506: 332-5. PMID 22155095 DOI: 10.1016/J.Neulet.2011.11.039  0.359
2012 Lisi L, Tramutola A, De Luca A, Navarra P, Dello Russo C. Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120. Journal of Neurochemistry. 120: 106-14. PMID 22017448 DOI: 10.1111/J.1471-4159.2011.07549.X  0.73
2012 Graziani G, Tentori L, Navarra P. Ipilimumab: a novel immunostimulatory monoclonal antibody for the treatment of cancer. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 65: 9-22. PMID 21930211 DOI: 10.1016/J.Phrs.2011.09.002  0.309
2011 de Corato A, Capuano A, Currò D, Tringali G, Navarra P, Dello Russo C. Trigeminal satellite cells modulate neuronal responses to triptans: relevance for migraine therapy. Neuron Glia Biology. 7: 109-16. PMID 22321965 DOI: 10.1017/S1740925X11000172  0.632
2011 De Corato A, Lisi L, Capuano A, Tringali G, Tramutola A, Navarra P, Dello Russo C. Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects. Journal of Neuroimmunology. 237: 39-46. PMID 21719118 DOI: 10.1016/J.Jneuroim.2011.05.013  0.735
2011 Dello Russo C, Lisi L, Lofaro A, Di Giambenedetto S, Federico B, Madeddu G, Salerno M, Mura MS, Pirazzoli A, de Luca A, Cauda R, Navarra P. Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR. Pharmacogenomics. 12: 567-76. PMID 21521028 DOI: 10.2217/Pgs.10.208  0.685
2011 Lisi L, Navarra P, Feinstein DL, Dello Russo C. The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes. Journal of Neuroinflammation. 8: 1. PMID 21208419 DOI: 10.1186/1742-2094-8-1  0.777
2011 Capuano A, Currò D, Navarra P, Tringali G. Cortistatin modulates calcitonin gene-related peptide release from neuronal tissues of rat. Comparison with somatostatin. Peptides. 32: 138-43. PMID 20883741 DOI: 10.1016/J.Peptides.2010.09.018  0.339
2010 D'Amico M, Samengo I, Navarra P, Taglialatela M, Martire M. AMPA- and P2X7-receptor-mediated facilitation of [3H]D-aspartate release from nerve terminals isolated from the rat caudal brainstem. Neurochemistry International. 57: 623-8. PMID 20673841 DOI: 10.1016/J.Neuint.2010.07.009  0.318
2010 Capuano A, De Corato A, Treglia M, Tringali G, Currò D, Dello Russo C, Navarra P. Peripheral antinociceptive effects of low doses of naloxone in an in vivo and in vitro model of trigeminal nociception. Neuropharmacology. 58: 784-92. PMID 20036676 DOI: 10.1016/J.Neuropharm.2009.12.012  0.629
2009 Capuano A, De Corato A, Lisi L, Tringali G, Navarra P, Dello Russo C. Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology. Molecular Pain. 5: 43. PMID 19660121 DOI: 10.1186/1744-8069-5-43  0.74
2009 Dello Russo C, Lisi L, Tringali G, Navarra P. Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation. Biochemical Pharmacology. 78: 1242-51. PMID 19576187 DOI: 10.1016/J.Bcp.2009.06.097  0.752
2009 Dello Russo C, Lisi L, Navarra P, Tringali G. Diverging effects of cortistatin and somatostatin on the production and release of prostanoids from rat cortical microglia and astrocytes. Journal of Neuroimmunology. 213: 78-83. PMID 19552966 DOI: 10.1016/J.Jneuroim.2009.05.016  0.735
2009 Tringali G, Lisi L, De Simone ML, Aubry JM, Preziosi P, Pozzoli G, Navarra P. Effects of olanzapine and quetiapine on corticotropin-releasing hormone release in the rat brain. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 33: 1017-21. PMID 19467289 DOI: 10.1016/J.Pnpbp.2009.05.012  0.585
2009 Capuano A, De Corato A, Tringali G, Currò D, Dello Russo C, Navarra P. Buprenorphine inhibits bradykinin-induced release of calcitonin gene-related peptide from rat trigeminal neurons via both mu-opioid and nociceptin/orphanin peptide receptors. European Journal of Pharmacology. 609: 45-50. PMID 19285495 DOI: 10.1016/J.Ejphar.2009.03.013  0.631
2009 Capuano A, De Corato A, Treglia M, Tringali G, Dello Russo C, Navarra P. Antinociceptive activity of buprenorphine and lumiracoxib in the rat orofacial formalin test: a combination analysis study. European Journal of Pharmacology. 605: 57-62. PMID 19168053 DOI: 10.1016/J.Ejphar.2008.12.029  0.627
2008 Tringali G, Lisi L, Bettella F, Renier D, Di Stasi SM, Navarra P. The in vitro rabbit whole bladder as a model to investigate the urothelial transport of anticancer agents The ONCOFID-P paradigm. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 58: 340-3. PMID 18848989 DOI: 10.1016/J.Phrs.2008.09.008  0.542
2008 Iacopino F, Urbano R, Graziani G, Muzi A, Navarra P, Sica G. Valproic acid activity in androgen-sensitive and -insensitive human prostate cancer cells. International Journal of Oncology. 32: 1293-303. PMID 18497991 DOI: 10.3892/Ijo_32_6_1293  0.334
2008 Tentori L, Muzi A, Dorio AS, Bultrini S, Mazzon E, Lacal PM, Shah GM, Zhang J, Navarra P, Nocentini G, Cuzzocrea S, Graziani G. Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity. European Journal of Cancer (Oxford, England : 1990). 44: 1302-14. PMID 18440222 DOI: 10.1016/J.Ejca.2008.03.019  0.334
2008 Tentori L, Dorio AS, Muzi A, Lacal PM, Ruffini F, Navarra P, Graziani G. The integrin antagonist cilengitide increases the antitumor activity of temozolomide against malignant melanoma. Oncology Reports. 19: 1039-43. PMID 18357394 DOI: 10.3892/Or.19.4.1039  0.327
2007 Capuano A, Currò D, Dello Russo C, Tringali G, Pozzoli G, Di Trapani G, Navarra P. Nociceptin (1-13)NH2 inhibits stimulated calcitonin-gene-related-peptide release from primary cultures of rat trigeminal ganglia neurones. Cephalalgia : An International Journal of Headache. 27: 868-76. PMID 17640294 DOI: 10.1111/J.1468-2982.2007.01354.X  0.654
2007 Tringali G, Pozzoli G, Lisi L, Navarra P. Erythropoietin inhibits basal and stimulated corticotropin-releasing hormone release from the rat hypothalamus via a nontranscriptional mechanism. Endocrinology. 148: 4711-5. PMID 17615151 DOI: 10.1210/En.2007-0431  0.589
2007 Graziani G, Tentori L, Muzi A, Vergati M, Tringali G, Pozzoli G, Navarra P. Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype. Molecular and Cellular Endocrinology. 264: 44-9. PMID 17097220 DOI: 10.1016/J.Mce.2006.10.006  0.344
2006 Tringali G, Aubry JM, Navarra P, Pozzoli G. Lamotrigine inhibits basal and Na+-stimulated, but not Ca2+-stimulated, release of corticotropin-releasing hormone from the rat hypothalamus. Psychopharmacology. 188: 386-92. PMID 16947017 DOI: 10.1007/S00213-006-0539-4  0.354
2006 Navarra P, Tringali G, Fabricio AS, Proietti A, Vairano M, Pozzoli G, Preziosi P. Hydroxyurea induces vasopressin release and cytokine gene expression in the rat hypothalamus. Journal of Neuroimmunology. 179: 94-100. PMID 16844235 DOI: 10.1016/J.Jneuroim.2006.06.007  0.395
2006 Galli M, Toriani Terenzi C, Falcone G, Pozzetto U, Tringali G, De Santis V, Vairano M, Navarra P, Pozzoli G. Metallic but not ceramic wear particles increase prostaglandin E2 release and interleukin-1beta gene expression in human blood monocytes in vitro. International Journal of Molecular Medicine. 18: 141-5. PMID 16786165 DOI: 10.1007/978-3-7985-1635-9_51  0.351
2006 Misiti F, Clementi ME, Tringali G, Vairano M, Orsini F, Pezzotti M, Navarra P, Giardina B, Pozzoli G. Fragment 31-35 of beta-amyloid peptide induces neurodegeneration in rat cerebellar granule cells via bax gene expression and caspase-3 activation. A crucial role for the redox state of methionine-35 residue. Neurochemistry International. 49: 525-32. PMID 16720060 DOI: 10.1016/J.Neuint.2006.03.014  0.33
2006 Pozzoli G, Tringali G, Vairano M, D'Amico M, Navarra P, Martire M. Cannabinoid agonist WIN55,212-2 induces apoptosis in cerebellar granule cells via activation of the CB1 receptor and downregulation of bcl-xL gene expression. Journal of Neuroscience Research. 83: 1058-65. PMID 16609959 DOI: 10.1002/Jnr.20794  0.346
2006 Fabricio AS, Tringali G, Pozzoli G, Melo MC, Vercesi JA, Souza GE, Navarra P. Interleukin-1 mediates endothelin-1-induced fever and prostaglandin production in the preoptic area of rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 290: R1515-23. PMID 16455768 DOI: 10.1152/Ajpregu.00604.2005  0.329
2006 Graziani G, Ferrandina G, Pozzoli G, Vergati M, Muzi A, Legge F, Tentori L, Scambia G, Navarra P. Corticotropin-releasing hormone receptor-1 in human endometrial cancer. Oncology Reports. 15: 375-9. PMID 16391857 DOI: 10.3892/Or.15.2.375  0.323
2005 Tringali G, Pozzoli G, Vairano M, Mores N, Preziosi P, Navarra P. Interleukin-18 displays effects opposite to those of interleukin-1 in the regulation of neuroendocrine stress axis. Journal of Neuroimmunology. 160: 61-7. PMID 15710458 DOI: 10.1016/J.Jneuroim.2004.10.028  0.334
2005 Palozza P, Serini S, Maggiano N, Tringali G, Navarra P, Ranelletti FO, Calviello G. beta-Carotene downregulates the steady-state and heregulin-alpha-induced COX-2 pathways in colon cancer cells. The Journal of Nutrition. 135: 129-36. PMID 15623844 DOI: 10.1093/Jn/135.1.129  0.345
2005 Fabricio AS, Veiga FH, Cristofoletti R, Navarra P, Souza GE. The effects of selective and nonselective cyclooxygenase inhibitors on endothelin-1-induced fever in rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 288: R671-7. PMID 15539607 DOI: 10.1152/Ajpregu.00532.2004  0.305
2005 Fabricio AS, Tringali G, Pozzoli G, Navarra P. Mirtazapine acutely inhibits basal and K(+)-stimulated release of corticotropin-releasing hormone from the rat hypothalamus via a non-genomic mechanism. Psychopharmacology. 178: 78-82. PMID 15300357 DOI: 10.1007/S00213-004-1984-6  0.349
2004 Calviello G, Di Nicuolo F, Gragnoli S, Piccioni E, Serini S, Maggiano N, Tringali G, Navarra P, Ranelletti FO, Palozza P. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. Carcinogenesis. 25: 2303-10. PMID 15358633 DOI: 10.1093/Carcin/Bgh265  0.314
2004 Vairano M, Graziani G, Tentori L, Tringali G, Navarra P, Dello Russo C. Primary cultures of microglial cells for testing toxicity of anticancer drugs. Toxicology Letters. 148: 91-4. PMID 15019092 DOI: 10.1016/J.Toxlet.2003.12.058  0.661
2004 Tringali G, Vairano M, Dello Russo C, Preziosi P, Navarra P. Lovastatin and mevastatin reduce basal and cytokine-stimulated production of prostaglandins from rat microglial cells in vitro: evidence for a mechanism unrelated to the inhibition of hydroxy-methyl-glutaryl CoA reductase. Neuroscience Letters. 354: 107-10. PMID 14698450 DOI: 10.1016/J.Neulet.2003.09.066  0.664
2003 Miceli F, Tringali G, Tropea A, Minici F, Orlando MT, Lanzone A, Navarra P, Apa R. The effects of nitric oxide on prostanoid production and release by human umbilical vein endothelial cells. Life Sciences. 73: 2533-42. PMID 12967678 DOI: 10.1016/S0024-3205(03)00659-3  0.365
2003 Graziani G, Tentori L, Portarena I, Vergati M, Navarra P. Valproic acid increases the stimulatory effect of estrogens on proliferation of human endometrial adenocarcinoma cells. Endocrinology. 144: 2822-8. PMID 12810536 DOI: 10.1210/En.2002-0180  0.349
2003 Miceli F, Tropea A, Minici F, Navarra P, Lanzone A, Apa R. Interleukin-1 beta stimulates progesterone production by in vitro human luteal cells: evidence of a mediatory role of prostaglandins. The Journal of Clinical Endocrinology and Metabolism. 88: 2690-4. PMID 12788874 DOI: 10.1210/Jc.2002-020819  0.335
2002 Vairano M, Dello Russo C, Pozzoli G, Battaglia A, Scambia G, Tringali G, Aloe-Spiriti MA, Preziosi P, Navarra P. Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro. The European Journal of Neuroscience. 16: 584-92. PMID 12270034 DOI: 10.1046/J.1460-9568.2002.02125.X  0.674
2002 Tentori L, Portarena I, Torino F, Scerrati M, Navarra P, Graziani G. Poly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G(2)/M cell accumulation induced by temozolomide in malignant glioma cells. Glia. 40: 44-54. PMID 12237842 DOI: 10.1002/Glia.10113  0.335
2002 Graziani G, Tentori L, Portarena I, Barbarino M, Tringali G, Pozzoli G, Navarra P. CRH inhibits cell growth of human endometrial adenocarcinoma cells via CRH-receptor 1-mediated activation of cAMP-PKA pathway. Endocrinology. 143: 807-13. PMID 11861501 DOI: 10.1210/Endo.143.3.8694  0.382
2001 Navarra P, Vairano M, Costa A, Grossman A. The roles of carbon monoxide and nitric oxide in the control of the neuroendocrine stress response: complementary or redundant. Stress (Amsterdam, Netherlands). 4: 3-11. PMID 22432123 DOI: 10.3109/10253890109001139  0.354
2001 Pozzoli G, Tringali G, Dello Russo C, Vairano M, Preziosi P, Navarra P. HIV-1 Gp120 protein modulates corticotropin releasing factor synthesis and release via the stimulation of its mRNA from the rat hypothalamus in vitro: involvement of inducible nitric oxide synthase. Journal of Neuroimmunology. 118: 268-76. PMID 11498261 DOI: 10.1016/S0165-5728(01)00351-4  0.651
2001 Navarra P, Miceli F, Tringali G, Minici F, Pardo MG, Lanzone A, Mancuso S, Apa R. Evidence for a functional link between the heme oxygenase-carbon monoxide pathway and corticotropin-releasing hormone release from primary cultures of human trophoblast cells. The Journal of Clinical Endocrinology and Metabolism. 86: 317-23. PMID 11232018 DOI: 10.1210/Jcem.86.1.7091  0.388
2001 Vairano M, Dello Russo C, Pozzoli G, Tringali G, Preziosi P, Navarra P. A functional link between heme oxygenase and cyclo-oxygenase activities in cortical rat astrocytes. Biochemical Pharmacology. 61: 437-41. PMID 11226377 DOI: 10.1016/S0006-2952(00)00582-7  0.625
2000 Pistritto G, Ciabattoni G, Mancuso C, Tringali G, Preziosi P, Navarra P. Signaling pathways involved in lipopolysaccharide stimulation of prostaglandin production by rat hypothalamic astroglial cells. Journal of Endotoxin Research. 6: 307-11. PMID 11521051 DOI: 10.1177/09680519000060040601  0.362
2000 Navarra P, Dello Russo C, Mancuso C, Preziosi P, Grossman A. Gaseous neuromodulators in the control of neuroendocrine stress axis. Annals of the New York Academy of Sciences. 917: 638-46. PMID 11268392 DOI: 10.1111/J.1749-6632.2000.Tb05429.X  0.646
2000 Navarra P, Aloe-Spiriti MA, Boccarini F, Montefusco E, Latagliata R, Preziosi P, Petti MC. A case-control study of the effects of hydroxyurea on circulating cortisol levels in patients with acute myelogenous leukemia and chronic myeloproliferative disorders. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 42: 389-92. PMID 10988000 DOI: 10.1006/Phrs.2000.0709  0.316
2000 Tringali G, Dello Russo C, Preziosi P, Navarra P. Interleukin-1 in the central nervous system: from physiology to pathology. Thã©Rapie. 55: 171-5. PMID 10860021  0.6
2000 Tringali G, Farrace S, Ragazzoni E, Dello Russo C, Piscitelli R, Preziosi P, Navarra P. Circulating interleukin-1-beta levels after acute and prolonged exposure to low temperatures: human and rat studies. Neuroimmunomodulation. 7: 177-81. PMID 10810249  0.592
2000 Dello Russo C, Tringali G, Ragazzoni E, Maggiano N, Menini E, Vairano M, Preziosi P, Navarra P. Evidence that hydrogen sulphide can modulate hypothalamo-pituitary-adrenal axis function: in vitro and in vivo studies in the rat. Journal of Neuroendocrinology. 12: 225-33. PMID 10718918 DOI: 10.1046/j.1365-2826.2000.00441.x  0.612
1999 Tringali G, Dello Russo C, Vairano M, Preziosi P, Navarra P. Depolarization and a NO-donor stimulate interleukin-1beta release from the rat hypothalamus via a mechanism involving caspase 1. Neuroscience Letters. 276: 119-22. PMID 10624806 DOI: 10.1016/S0304-3940(99)00806-X  0.635
1999 Mancuso C, Ragazzoni E, Tringali G, Liberale I, Preziosi P, Grossman A, Navarra P. Inhibition of heme oxygenase in the central nervous system potentiates endotoxin-induced vasopressin release in the rat. Journal of Neuroimmunology. 99: 189-94. PMID 10505974 DOI: 10.1016/S0165-5728(99)00112-5  0.35
1999 Pistritto G, Franzese O, Pozzoli G, Mancuso C, Tringali G, Preziosi P, Navarra P. Bacterial lipopolysaccharide increases prostaglandin production by rat astrocytes via inducible cyclo-oxygenase: evidence for the involvement of nuclear factor kappaB. Biochemical and Biophysical Research Communications. 263: 570-4. PMID 10491333 DOI: 10.1006/Bbrc.1999.1413  0.343
1998 Tringali G, Dello Russo C, Preziosi P, Navarra P. Hypothalamic interleukin-1 in physiology and pathology. Toxicology Letters. 102: 295-9. PMID 10022269 DOI: 10.1016/S0378-4274(98)00318-X  0.65
1998 Grimaldi M, Navarra P, Pozzoli G, Preziosi P, Schettini G. Bacterial lipopolysaccharide increases interleukin-6 and prostaglandin release in rat cortical type I astrocytes by different mechanisms: role of anti-inflammatory agents. Biochemical and Biophysical Research Communications. 250: 798-804. PMID 9784426 DOI: 10.1006/Bbrc.1998.9378  0.352
1998 Kostoglou-Athanassiou I, Costa A, Navarra P, Nappi G, Forsling ML, Grossman AB. Endotoxin stimulates an endogenous pathway regulating corticotropin-releasing hormone and vasopressin release involving the generation of nitric oxide and carbon monoxide. Journal of Neuroimmunology. 86: 104-9. PMID 9655478 DOI: 10.1016/S0165-5728(98)00028-9  0.353
1998 Kostoglou-Athanassiou I, Jacobs RA, Satta MA, Dahia PL, Costa A, Navarra P, Chew SL, Forsling ML, Grossman AB. Acute and subacute effects of endotoxin on hypothalamic gaseous neuromodulators. Annals of the New York Academy of Sciences. 840: 249-61. PMID 9629253 DOI: 10.1111/J.1749-6632.1998.Tb09565.X  0.369
1998 Pistritto G, Mancuso C, Tringali G, Perretti M, Preziosi P, Navarra P. The relative contribution of constitutive and inducible cyclooxygenase activity to lipopolysaccharide-induced prostaglandin production by primary cultures of rat hypothalamic astrocytes. Neuroscience Letters. 246: 45-8. PMID 9622204 DOI: 10.1016/S0304-3940(98)00226-2  0.352
1998 Mancuso C, Tringali G, Grossman A, Preziosi P, Navarra P. The generation of nitric oxide and carbon monoxide produces opposite effects on the release of immunoreactive interleukin-1beta from the rat hypothalamus in vitro: evidence for the involvement of different signaling pathways. Endocrinology. 139: 1031-7. PMID 9492035 DOI: 10.1210/Endo.139.3.5822  0.356
1997 Mancuso C, Preziosi P, Grossman AB, Navarra P. The role of carbon monoxide in the regulation of neuroendocrine function. Neuroimmunomodulation. 4: 225-9. PMID 9650814 DOI: 10.1159/000097340  0.36
1997 Tringali G, Mirtella A, Mancuso C, Guerriero G, Preziosi P, Navarra P. The release of immunoreactive interleukin-1 beta from rat hypothalamic explants is modulated by neurotransmitters and corticotropin-releasing hormone. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 36: 269-73. PMID 9425615 DOI: 10.1006/Phrs.1997.0235  0.343
1997 Mancuso C, Kostoglou-Athanassiou I, Forsling ML, Grossman AB, Preziosi P, Navarra P, Minotti G. Activation of heme oxygenase and consequent carbon monoxide formation inhibits the release of arginine vasopressin from rat hypothalamic explants. Molecular linkage between heme catabolism and neuroendocrine function. Brain Research. Molecular Brain Research. 50: 267-76. PMID 9406943 DOI: 10.1016/S0169-328X(97)00197-6  0.354
1997 Mancuso C, Pistritto G, Tringali G, Grossman AB, Preziosi P, Navarra P. Evidence that carbon monoxide stimulates prostaglandin endoperoxide synthase activity in rat hypothalamic explants and in primary cultures of rat hypothalamic astrocytes. Brain Research. Molecular Brain Research. 45: 294-300. PMID 9149104 DOI: 10.1016/S0169-328X(96)00258-6  0.382
1996 Kostoglou-Athanassiou I, Forsling ML, Navarra P, Grossman AB. Oxytocin release is inhibited by the generation of carbon monoxide from the rat hypothalamus--further evidence for carbon monoxide as a neuromodulator. Brain Research. Molecular Brain Research. 42: 301-6. PMID 9013787 DOI: 10.1016/S0169-328X(96)00137-4  0.353
1996 Navarra P, Andreani CL, Lazzarin N, Pierro E, Mirtella A, Lanzone A, Mancuso S. Increased production and release of prostaglandin-E2 by human granulosa cells from polycystic ovaries. Prostaglandins. 52: 187-97. PMID 8908619 DOI: 10.1016/S0090-6980(96)00096-2  0.331
1996 Montuschi P, Tringali G, Mirtella A, Parente L, Ragazzoni E, Preziosi P, Navarra P. Interleukin-1 beta release from rat gastric fundus. The American Journal of Physiology. 271: G275-81. PMID 8770043 DOI: 10.1152/Ajpgi.1996.271.2.G275  0.32
1996 Navarra P, Tringali G, Preziosi P. The effects of inhibitors of cyclo-oxygenase, lipoxygenase and nitric oxide synthase pathways on the toxicity of hydroxyurea in adrenalectomized rats. Toxicology Letters. 86: 13-18. PMID 8685915 DOI: 10.1016/0378-4274(96)03666-1  0.331
1996 Ambrosetti DC, Palla E, Mirtella A, Galeotti C, Solito E, Navarra P, Parente L, Melli M. Synthetic alleles at position 121 define a functional domain of human interleukin-1 beta. European Journal of Biochemistry / Febs. 238: 308-16. PMID 8681939 DOI: 10.1111/J.1432-1033.1996.0308Z.X  0.306
1995 Navarra P, Puccetti P, Riccardi C, Preziosi P. Anticancer drug toxicity via cytokine production: the hydroxyurea paradigm. Toxicology Letters. 82: 167-71. PMID 8597047 DOI: 10.1016/0378-4274(95)03552-4  0.348
1995 Montuschi P, Tringali G, Mirtella A, Parente L, Preziosi P, Navarra P. Interleukin-1 receptor antagonist displays intrinsic agonist activity on rat gastric fundus motility in vitro. European Journal of Pharmacology. 275: 31-7. PMID 7774660 DOI: 10.1016/0014-2999(94)00730-U  0.33
1995 Mirtella A, Tringali G, Guerriero G, Ghiara P, Parente L, Preziosi P, Navarra P. Evidence that the interleukin-1 beta-induced prostaglandin E2 release from rat hypothalamus is mediated by type I and type II interleukin-1 receptors. Journal of Neuroimmunology. 61: 171-7. PMID 7593552 DOI: 10.1016/0165-5728(95)00088-J  0.34
1995 Montuschi P, Tringali G, Mirtella A, Parente L, Preziosi P, Navarra P. Corrigendum to ‘Interleukin-1 receptor antagonist displays intrinsic agonist activity on rat gastric fundus motility in vitro’ [Eur. J. Pharmacol. 275 (1995) 31–37] European Journal of Pharmacology. 282: 263. DOI: 10.1016/0014-2999(95)00235-D  0.324
1994 Mirtella A, Pozzoli G, Preziosi P, Grossman A, Navarra P. Release of immunoreactive interleukin-1-alpha from rat hypothalamic explants is increased by bacterial lipopolysaccharide and high KCL concentrations. Neuroimmunomodulation. 1: 23-7. PMID 8528881 DOI: 10.1159/000097086  0.308
1994 Grimaldi M, Pozzoli G, Navarra P, Preziosi P, Schettini G. Vasoactive intestinal peptide and forskolin stimulate interleukin 6 production by rat cortical astrocytes in culture via a cyclic AMP-dependent, prostaglandin-independent mechanism. Journal of Neurochemistry. 63: 344-50. PMID 8207438 DOI: 10.1046/J.1471-4159.1994.63010344.X  0.32
1994 Montuschi P, Tringali G, Currò D, Ciabattoni G, Parente L, Preziosi P, Navarra P. Evidence that interleukin-1 beta and tumor necrosis factor inhibit gastric fundus motility via the 5-lipoxygenase pathway. European Journal of Pharmacology. 252: 253-60. PMID 8162947 DOI: 10.1016/0014-2999(94)90170-8  0.344
1994 Pozzoli G, Costa A, Grimaldi M, Schettini G, Preziosi P, Grossman A, Navarra P. Lipopolysaccharide modulation of eicosanoid and corticotrophin-releasing hormone release from rat hypothalamic explants and astrocyte cultures in vitro: evidence for the involvement of prostaglandin E2 but not prostaglandin F2 alpha and lack of effect of nerve growth factor. The Journal of Endocrinology. 140: 103-9. PMID 8138745 DOI: 10.1677/Joe.0.1400103  0.339
1994 Pozzoli G, Mancuso C, Mirtella A, Preziosi P, Grossman AB, Navarra P. Carbon monoxide as a novel neuroendocrine modulator: inhibition of stimulated corticotropin-releasing hormone release from acute rat hypothalamic explants. Endocrinology. 135: 2314-7. PMID 7988414 DOI: 10.1210/Endo.135.6.7988414  0.356
1994 Montuschi P, Tringali G, Parente L, Preziosi P, Navarra P. Interleukin-1 beta- and tumour-necrosis-factor-induced inhibition of rat gastric fundus motility in vitro. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 30: 25-33. PMID 7831192 DOI: 10.1016/1043-6618(94)80084-7  0.343
1994 Schettini G, Grimaldi M, Navarra P, Pozzoli G, Reichlin S, Preziosi P. Regulation of interleukin 6 production by cAMP-protein kinase-A pathway in rat cortical astrocytes. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 30: 13-24. PMID 7831191 DOI: 10.1016/1043-6618(94)80083-9  0.324
1993 Navarra P, Pozzoli G, Becherucci C, Preziosi P, Grossman AB, Parente L. Prostaglandin E2 and bacterial lipopolysaccharide stimulate bioactive interleukin-1 release from rat hypothalamic explants. Neuroendocrinology. 57: 257-61. PMID 8510801 DOI: 10.1159/000126367  0.331
1992 Navarra P, Pozzoli G, Brunetti L, Ragazzoni E, Besser M, Grossman A. Interleukin-1 beta and interleukin-6 specifically increase the release of prostaglandin E2 from rat hypothalamic explants in vitro. Neuroendocrinology. 56: 61-8. PMID 1641074 DOI: 10.1159/000126209  0.321
1992 Navarra P, Pozzoli G, Becherucci C, Parente L, Preziosi P. The role of eicosanoids in cytokine-induced release of CRH-41 from acute rat hypotalamic explants Pharmacological Research. 26: 114. DOI: 10.1016/1043-6618(92)90938-8  0.319
1991 Navarra P, Tsagarakis S, Faria MS, Rees LH, Besser GM, Grossman AB. Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology. 128: 37-44. PMID 1846105 DOI: 10.1210/Endo-128-1-37  0.353
1991 Honegger J, Spagnoli A, D'Urso R, Navarra P, Tsagarakis S, Besser GM, Grossman AB. Interleukin-1 beta modulates the acute release of growth hormone-releasing hormone and somatostatin from rat hypothalamus in vitro, whereas tumor necrosis factor and interleukin-6 have no effect. Endocrinology. 129: 1275-82. PMID 1678697 DOI: 10.1210/Endo-129-3-1275  0.361
1990 Navarra P, Del Carmine R, Ciabattoni G, D'Amato M, Ragazzoni E, Vacca M, Volpe AR, Preziosi P. Hydroxyurea: relationship between toxicity and centrally-induced adrenal activation. Pharmacology & Toxicology. 67: 209-15. PMID 2255677 DOI: 10.1111/J.1600-0773.1990.Tb00815.X  0.32
1990 Navarra P, Tzagarakis S, Preziosi P, Besser GM, Grossman A. Citokines modulate the release of CRH-41 from rat hypothalamic explants in vitro Pharmacological Research. 22: 352. DOI: 10.1016/S1043-6618(09)80370-8  0.302
1989 Preziosi P, Vacca M, Ragazzoni E, del Carmine R, Navarra P. Stress hormone changes after toxic doses of new anticancer drugs. Archives of Toxicology. Supplement. = Archiv Fã¼R Toxikologie. Supplement. 13: 436-9. PMID 2549916 DOI: 10.1007/978-3-642-74117-3_86  0.314
Show low-probability matches.